Alpharix

Alpharix is a vaccine designed to protect against influenza strains, including Influenza Virus B/Austria/1359417/2021-Like Strain and Influenza A/Vic. This intramuscular vaccine is manufactured by Glaxosmithkline Biologicals S.A. and is intended for seasonal flu prevention.

Alpharix is used to prevent influenza caused by specific strains of the virus. It is administered intramuscularly and is typically recommended for individuals seeking protection against seasonal flu. The vaccine works by stimulating the body's immune response to these influenza strains, helping to reduce the risk of infection.

Common effects of Alpharix may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or muscle aches following vaccination. These effects are generally mild and short-lived.

Alpharix should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of its components should consult their healthcare provider before receiving this vaccine. It is important to inform your healthcare provider about any current medications or health conditions.

Alpharix may interact with certain medications or health conditions. It is advisable to discuss any current medications, including over-the-counter drugs and supplements, with a healthcare provider before receiving the vaccine. Additionally, individuals with weakened immune systems should consult their healthcare provider for personalized advice.